134 related articles for article (PubMed ID: 22573368)
1. First-pass metabolism of decursin, a bioactive compound of Angelica gigas, in rats.
Park HS; Kim B; Oh JH; Kim YC; Lee YJ
Planta Med; 2012 Jun; 78(9):909-13. PubMed ID: 22573368
[TBL] [Abstract][Full Text] [Related]
2. Single oral dose pharmacokinetics of decursin, decursinol angelate, and decursinol in rats.
Li L; Zhang J; Xing C; Kim SH; Lü J
Planta Med; 2013 Mar; 79(3-4):275-80. PubMed ID: 23364885
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic characterization of decursinol derived from Angelica gigas Nakai in rats.
Song JS; Chae JW; Lee KR; Lee BH; Choi EJ; Ahn SH; Kwon KI; Bae MA
Xenobiotica; 2011 Oct; 41(10):895-902. PubMed ID: 21657833
[TBL] [Abstract][Full Text] [Related]
4. Biopharmaceutical characterization of decursin and their derivatives for drug discovery.
Mahat B; Chae JW; Baek IH; Song GY; Song JS; Ma JY; Kwon KI
Drug Dev Ind Pharm; 2013 Oct; 39(10):1523-30. PubMed ID: 23003006
[TBL] [Abstract][Full Text] [Related]
5. Decursinol and decursin protect primary cultured rat cortical cells from glutamate-induced neurotoxicity.
Kang SY; Kim YC
J Pharm Pharmacol; 2007 Jun; 59(6):863-70. PubMed ID: 17637179
[TBL] [Abstract][Full Text] [Related]
6. Quantitative determination of decursin, decursinol angelate, and decursinol in mouse plasma and tumor tissue using liquid-liquid extraction and HPLC.
Li L; Zhang J; Shaik AA; Zhang Y; Wang L; Xing C; Kim SH; Lü J
Planta Med; 2012 Feb; 78(3):252-9. PubMed ID: 22116603
[TBL] [Abstract][Full Text] [Related]
7. Absorption, distribution, metabolism, and excretion of decursin and decursinol angelate from Angelica gigas Nakai.
Kim KM; Kim MJ; Kang JS
J Microbiol Biotechnol; 2009 Dec; 19(12):1569-72. PubMed ID: 20075620
[TBL] [Abstract][Full Text] [Related]
8. Biotransformation of plant secondary metabolite decursin by Mycobacterium sp. PYR1001.
Kim KY; Lee S; Cha CJ
J Agric Food Chem; 2010 Mar; 58(5):2931-4. PubMed ID: 20155945
[TBL] [Abstract][Full Text] [Related]
9. Prostate Cancer Xenograft Inhibitory Activity and Pharmacokinetics of Decursinol, a Metabolite of Angelica gigas Pyranocoumarins, in Mouse Models.
Wu W; Tang SN; Zhang Y; Puppala M; Cooper TK; Xing C; Jiang C; Lü J
Am J Chin Med; 2017; 45(8):1773-1792. PubMed ID: 29121805
[TBL] [Abstract][Full Text] [Related]
10. Nanocomposites based on Soluplus and Angelica gigas Nakai extract fabricated by an electrohydrodynamic method for oral administration.
Lee JJ; Nam S; Park JH; Lee SY; Jeong JY; Lee JY; Kang WS; Yoon IS; Kim DD; Cho HJ
J Colloid Interface Sci; 2016 Dec; 484():146-154. PubMed ID: 27599383
[TBL] [Abstract][Full Text] [Related]
11. Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase.
Son SH; Kim MJ; Chung WY; Son JA; Kim YS; Kim YC; Kang SS; Lee SK; Park KK
Cancer Lett; 2009 Jul; 280(1):86-92. PubMed ID: 19307054
[TBL] [Abstract][Full Text] [Related]
12. Decursin and decursinol from Angelica gigas inhibit the lung metastasis of murine colon carcinoma.
Son SH; Park KK; Park SK; Kim YC; Kim YS; Lee SK; Chung WY
Phytother Res; 2011 Jul; 25(7):959-64. PubMed ID: 21170925
[TBL] [Abstract][Full Text] [Related]
13. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
Jung MH; Lee SH; Ahn EM; Lee YM
Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
[TBL] [Abstract][Full Text] [Related]
14. In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin.
Lee HJ; Lee HJ; Lee EO; Lee JH; Lee KS; Kim KH; Kim SH; Lü J
Am J Chin Med; 2009; 37(1):127-42. PubMed ID: 19222117
[TBL] [Abstract][Full Text] [Related]
15. Effects of Angelica gigas Nakai on the production of decursin- and decursinol angelate-enriched eggs.
Fontamillas GAD; Kim SW; Kim HU; Kim SJ; Kim JG; Park TS; Park BC
J Sci Food Agric; 2019 Apr; 99(6):3117-3123. PubMed ID: 30536922
[TBL] [Abstract][Full Text] [Related]
16. Decursin and decursinol angelate selectively inhibit NADH-fumarate reductase of Ascaris suum.
Shiomi K; Hatano H; Morimoto H; Ui H; Sakamoto K; Kita K; Tomoda H; Lee EW; Heo TR; Kawagishi H; Omura S
Planta Med; 2007 Nov; 73(14):1478-81. PubMed ID: 17948169
[TBL] [Abstract][Full Text] [Related]
17. Effect of decursin on the pharmacokinetics of theophylline and its metabolites in rats.
Chae JW; Baek IH; Kwon KI
J Ethnopharmacol; 2012 Nov; 144(2):248-54. PubMed ID: 22981724
[TBL] [Abstract][Full Text] [Related]
18. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer.
Jiang C; Lee HJ; Li GX; Guo J; Malewicz B; Zhao Y; Lee EO; Lee HJ; Lee JH; Kim MS; Kim SH; Lu J
Cancer Res; 2006 Jan; 66(1):453-63. PubMed ID: 16397261
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
Han KS; Lee MG
Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
[TBL] [Abstract][Full Text] [Related]
20. Pyranocoumarin Tissue Distribution, Plasma Metabolome and Prostate Transcriptome Impacts of Sub-Chronic Exposure to Korean Angelica Supplement in Mice.
Zhang J; Li L; Tang S; Zhang Y; Markiewski M; Xing C; Jiang C; Lü J
Am J Chin Med; 2016; 44(2):321-53. PubMed ID: 27080944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
